Now Available to Healthcare Providers for Clinical Use: The Industry’s First Exosome-Based Liquid Biopsy Tests
ExoDx®Prostate(IntelliScore) is the first clinically validated non-invasive, non-DRE, urine-based liquid biopsy test for prostate cancer.
ExoDx® Lung(ALK) is a plasma-based liquid biopsy assay that detects the EML4-ALK mutation and is highly specific for distinct EML4-ALK fusion transcripts.
ExoDx Prostate(IntelliScore) and ExoDx Lung(ALK) are Laboratory Developed Tests (LDT) performed in our laboratory.
ALREADY A CUSTOMER?
Please call Exosome Diagnostics client services at 1-844-EXOSOME (844 396 7663)
New client? Order tests by contacting Exosome Diagnostics' customer service at 1-844-EXOSOME or filling out the form below. Please note, we are not able to process orders from physicians based in New York. The tests are Laboratory Developed Tests (LDT's) per CLIA '88 and, as such must be ordered by a physician. The kits will only be shipped to physican offices.